The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Retrospective safety assessment of bendamustine in patients with renal impairment.
Beth L Nordstrom
Research Funding - Teva
Kevin B. Knopf
Consultant or Advisory Role - United Biosource Corporation
Dana Teltsch
Research Funding - Teva
Robert Engle
Research Funding - Teva
Hooman Beygi
Employment or Leadership Position - Teva
James A. Sterchele
Employment or Leadership Position - Teva